OREXO US INC

MORRISTOWN, NEW JERSEY 079603965

$16.90M
Total Contract Value
10 awards
First Award
Nov 8, 2022
Last Award
Sep 24, 2025
Business Size
small
CAGE Code
6Y7L3

Top Industries (NAICS)

NAICS CodeObligationsAwards
541714$8.45M1
325412$07
334510$01

Contract Awards

1 awards found

75A50125C00010
Department of Health and Human Services
$8.45M
Sep 24, 2025

CLINICAL DEVELOPMENT OF OX390 (ATIPAMEZOLE) AS AN ?2 AGONIST REVERSAL AGENT FOR HUMAN USE TO COUNTERACT THE SEDATIVE EFFECTS OF XYLAZINE, MEDETOMIDINE, AND OTHER ?2 AGONISTS

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025

Business Details

UEI
MN1MPMBCVVD5
CAGE Code
6Y7L3
Address
150 HEADQUARTERS PLZ EAST TOWER
MORRISTOWN, NJ 079603965
Congressional District
NJ-11

Parent Company

OREXO AB

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov